Sign in
CompletedPhase 4

Comparing Ketamine and Fentanyl in Pediatric Tonsillectomy: Pain Control and Emergence Delirium Outcomes (KVFPT)

Key facts

Who runs it
Medipol University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
59 people enrolled
Started
1 Jan 2023
Ended
15 Jun 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ketamine
  • fentanyl
Record updated
30 October 2024

Who can take part

Age
3 years to 8 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Children aged 3 to 8 years
  • Scheduled for tonsillectomy and adenoidectomy
  • American Society of Anesthesiologists (ASA) Physical Status I-III

Who cannot take part

  • Receiving chronic opioid analgesic therapy prior to surgery
  • Known hypersensitivity or allergy to any of the study medications (acetaminophen, ketamine, fentanyl)
  • Renal disease
  • Hepatic disease
  • Obesity (body mass index greater than 99th percentile for age)
  • American Society of Anesthesiologists' Physical Status ≥4

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is designed to compare the effectiveness of two medications, ketamine and fentanyl, in managing pain and preventing delirium in children aged 3 to 8 years who are undergoing tonsillectomy and adenoidectomy surgery. The study aims to determine which medication is better at reducing pain and preventing delirium after surgery, and which one results in faster recovery times and fewer side effects. Children participating in the study will be randomly assigned to receive either ketamine or fentanyl during their surgery. The study will measure pain levels, recovery times, and any side effects experienced by the children. The results of this study will help doctors and anesthesiologists make better decisions about which medication to use for pain management in children undergoing tonsillectomy and adenoidectomy.

The 2 groups in the trial

  • Group I (Ketamine group)Existing treatment, for comparison

    The patients in this group will have intravenous ketamine (0.5 mg/kg) during induction

    Treatment: ketamine

  • Group II (Fentanyl Group)Treatment being tested

    The patients in this group will have intravenous fentanyl (1 µg/kg) during induction

    Treatment: fentanyl

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Clinical Trial Comparing Ketamine and Fentanyl for Postoperative Pain Management and Emergence Delirium Following Pediatric Tonsillectomy and Adenoidectomy
Record updated
30 October 2024